Zika virus: from pathogenesis to disease control.

Area of Science:

• Virology
• Epidemiology
• Public Health

Background:

• Zika virus, a mosquito-borne flavivirus first identified in Uganda in 1947, has recently caused significant human outbreaks in the Pacific and Americas.
• Emergence factors remain unclear but likely involve introduction into susceptible environments with competent Aedes mosquitoes and dense human populations.
• Unique transmission routes include sexual and transplacental spread, leading to severe neurological complications such as Guillain-Barré syndrome and fetal microcephaly.

Approach:

• Diagnostic challenges arise from cross-reactivity in antibody detection, necessitating reliance on viral nucleic acid detection.
• Experimental studies, including those in animal models, investigate Zika virus pathogenesis, revealing its capacity to infect and replicate in placental and brain tissues.
• Animal models are crucial for evaluating potential antiviral therapies and vaccine candidates, with promising preliminary results.

Key Points:

• Zika virus poses a significant global health threat due to its rapid spread and severe neurological sequelae.
• Understanding transmission dynamics, including sexual and vertical routes, is critical for effective control strategies.
• Animal models provide valuable insights into disease mechanisms and serve as platforms for therapeutic and vaccine development.

Conclusions:

• Further research is needed to fully elucidate the factors driving Zika virus emergence and spread.
• Development of reliable diagnostic tools and effective antiviral interventions remains a priority.
• Continued investigation using advanced animal models holds promise for mitigating the impact of Zika virus infections.